New technology also can be used to turn off peanut and other food allergies
In an entirely new approach to treating asthma and allergies, a biodegradable nanoparticle acts like a Trojan horse, hiding an allergen in a friendly shell, to convince the immune system not to attack it, according to new Northwestern Medicine research. As a result, the allergic reaction in the airways is shut down long- term and an asthma attack prevented.
The technology can be applied to food allergies as well. The nanoparticle is currently being tested in a mouse model of peanut allergy, similar to food allergy in humans.
“The findings represent a novel, safe and effective long-term way to treat and potentially ‘cure’ patients with life-threatening respiratory and food allergies,” said senior author Stephen Miller, the Judy Gugenheim Research Professor of Microbiology-Immunology at Northwestern University Feinberg School of Medicine. “This may eliminate the need for life-long use of medications to treat lung allergy.”
It’s the first time this method for creating tolerance in the immune system has been used in allergic diseases. The approach has been used in autoimmune diseases including multiple sclerosis and celiac disease in previous preclinical Northwestern research.
The asthma allergy study was in mice, but the technology is progressing to clinical trials in autoimmune disease. The nanoparticle technology is being developed commercially by Cour Pharmaceuticals Development Co., which is working with Miller to bring this new approach to patients. A clinical trial using the nanoparticles to treat celiac disease is in development.
The new study on nanoparticles treating asthma was published April 18 in the Proceedings of the National Academy of Sciences.
“It’s a universal treatment,” Miller said. “Depending on what allergy you want to eliminate, you can load up the nanoparticle with ragweed pollen or a peanut protein.”
The nanoparticles are composed of an FDA-approved biopolymer called PLGA that includes lactic acid and glycolic acid.
Also a senior author is Lonnie Shea, adjunct professor of chemical and biological engineering at Northwestern’s McCormick School of Engineering and of obstetrics and gynecology at Feinberg, and chair of biomedical engineering at the University of Michigan.
When the allergen-loaded nanoparticle is injected into the bloodstream of mice, the immune system isn’t concerned with it because it sees the particle as innocuous debris. Then the nanoparticle and its hidden cargo are consumed by a macrophage, essentially a vacuum-cleaner cell.
“The vacuum-cleaner cell presents the allergen or antigen to the immune system in a way that says, ‘No worries, this belongs here,’” Miller said. The immune system then shuts down its attack on the allergen, and the immune system is reset to normal.
The allergen, in this case egg protein, was administered into the lungs of mice who have been pretreated to be allergic to the protein and already had antibodies in their blood against it. So when they were re-exposed to it, they responded with an allergic response like asthma. After being treated with the nanoparticle, they no longer had an allergic response to the allergen.
The approach also has a second benefit. It creates a more normal, balanced immune system by increasing the number of regulatory T cells, immune cells important for recognizing the airway allergens as normal. This method turns off the dangerous Th2 T cell that causes the allergy and expands the good, calming regulatory T cells.
The Latest on: Nanoparticles asthma allergies
via Google News
The Latest on: Nanoparticles asthma allergies
- Allergy Diagnostics Market Size & Growth Rate, Emerging Trends, Main Vendors, and Forecasts 2030on November 24, 2020 at 1:43 am
According to American Academy of Allergy, Asthma & Immunology ... Moreover, the exposure to the small nanoparticles in the air tends to exacerbate allergic inflammations. These factors are ...
- American Journal of Respiratory and Critical Care Medicineon November 23, 2020 at 1:12 pm
PM and asthma. Strickland and colleagues examined the association ... In a study that evaluated the mechanisms by which zinc oxide (ZnO) nanoparticles cause metal fume fever, Kim and colleagues found ...
- Interaction of Nanoparticles With Immunocompetent Cellson November 19, 2020 at 3:59 pm
As mentioned above, despite attempts to design nanomedicines capable of escaping immune recognition and entrapment, the majority of injected nanodrugs does still go to the RES. Even nanomedicines ...
- Food allergies take a greater emotional toll on Asian familieson November 12, 2020 at 9:20 pm
A new study being presented at this year's virtual American College of Allergy, Asthma and Immunology (ACAAI) Annual Scientific Meeting reveals the impact on food allergy quality of life (FAQOL ...
- New study points to a better way to ward off asthma triggerson November 10, 2020 at 4:00 pm
When a person with allergies encounters an asthma trigger, harmful T cells boost their numbers in the lungs and release molecules that cause inflammation. The new study shows how to throw a wrench ...
- Solar energy converted to steamon November 9, 2020 at 4:58 am
Rice University scientists have unveiled a revolutionary new technology that uses nanoparticles to convert solar energy directly into steam. The new “solar steam” method from Rice’s ...
- Flower power to treat cancerson November 9, 2020 at 4:58 am
A consortium of researchers led by WMG at the University of Warwick are to embark on a £3 million research programme called “Cleaning Land for Wealth” (CL4W), that will use a common class of ...
- Big Breakthrough On Coronavirus Vaccine: Nanoparticle Vaccine Candidate Produces COVID-19 Antibodieson November 3, 2020 at 9:30 pm
Professors at the University of Washington School of Medicine have had this success. It is a nanoparticle vaccine, whose initial testing was successful on mice. Now, this experimental vaccine will ...
- Should you wash your mane with horse shampoo?on November 2, 2020 at 5:13 pm
Avoid if you are allergic to horses ... who have a family history of cancer might have a higher risk of developing asthma, suggests a 2019 U.S. study. State University of New York researchers ...
- Production of a Nanoparticle Vaccine (image)on November 2, 2020 at 7:02 am
Production schematic shows how coronavirus proteins are added to a computer-designed nanoparticle platform to create a candidate vaccine against COVID-19. The vaccine candidate was designed and ...
via Bing News